A suprachoroidally injected CLS-TA, an investigational formulation of triamcinolone acetonide, yields significant improvements in vision of patients with macular oedema, according to the results of the phase III PEACHTREE study.
The combination of intravitreal aflibercept and antiplatelet-derived growth factor receptor β (anti-PDGFRβ) falls short of improving best-corrected visual acuity (BCVA) in patients with treatment-naïve neovascular age-related macular degeneration (nAMD), as compared with intravitreal aflibercept injection (IAI) monotherapy, a phase II study has shown.
The lutein and zeaxanthin status in pregnant women may play a significant role in the visual developmental trajectory of their offspring, such that higher concentrations of these two carotenoids protect against the risk of poor visual acuity (VA) in children, as reported in a study from Singapore.
Treatment with adjuvant corneal cross-linking (CXL) does not seem to produce favourable results in patients with moderate filamentous fungal ulcers and may even lead to reduced visual acuity, a recent study has shown.
Unusual involvement of the eyes with atypical presentations may occur in patients with inflammatory bowel diseases (IBD) on antitumour necrosis factor (anti-TNF) therapy, according to a recent study presented at the 2019 Advances in Inflammatory Bowel Diseases Annual Meeting (AIBD 2019).